Do I Qualify for GLP-1 Weight Management in Canada?

One of the most common questions people have about GLP-1 medications like semaglutide is a simple one: Do I even qualify?

It's a fair thing to want to know before booking a consultation. This guide walks through the eligibility criteria Health Canada set for semaglutide in chronic weight management, what "weight-related health conditions" means, who generally isn't a candidate, and why the final answer always comes from a licensed healthcare provider rather than a checklist online.

This article is educational and is not a substitute for medical advice. Semaglutide is a prescription medication, and eligibility is determined through a medical consultation.

The short answer

Health Canada authorized semaglutide (Wegovy) for chronic weight management in adults, as an adjunct to a reduced-calorie diet and increased physical activity, for people with:

• a BMI of 30 kg/m² or greater (classified as obesity), or

• a BMI of 27 kg/m² or greater (classified as overweight) with at least one weight-related health condition.

If you fall into one of those categories, you may be a candidate — but meeting the BMI threshold is the starting point of the conversation, not the whole of it.

What counts as a "weight-related health condition"?

For people in the overweight range (BMI 27–29.9), eligibility generally depends on having at least one health condition linked to weight. Common examples include:

• High blood pressure (hypertension)

• Type 2 diabetes

• High cholesterol or other lipid problems (dyslipidemia)

• Obstructive sleep apnea

These are the conditions most often cited alongside the Health Canada indication. Whether a specific condition qualifies you is a clinical judgment your provider makes based on your full health picture.

Understanding BMI — and its limits

BMI (body mass index) is a screening number calculated from your height and weight. It's the metric Health Canada's indication is written around, so it's a practical starting point.

But BMI is a blunt instrument. It doesn't distinguish muscle from fat, and it doesn't capture where weight is carried or your overall metabolic health. That's exactly why eligibility isn't decided by a number alone. The Canadian Adult Obesity Clinical Practice Guideline frames obesity as a chronic disease to be assessed and managed based on overall health — not treated as a simple height-and-weight equation. A good clinical assessment looks at the whole person, not just the BMI figure.

You can calculate your approximate BMI ahead of a consultation to get a sense of where you fall, but treat it as one input among several, not a verdict.

Who generally isn't a candidate?

Semaglutide isn't suitable for everyone. While only a provider can make this determination, treatment is generally not appropriate — or requires special caution — for people who:

• Are under 18 (the weight-management authorization is for adults)

• Are pregnant, breastfeeding, or planning to become pregnant

• Have a personal or family history of certain thyroid cancers (medullary thyroid carcinoma) or a specific endocrine condition (MEN 2)

• Have had a serious allergic reaction to semaglutide or its ingredients

• Have certain histories such as pancreatitis or specific gastrointestinal conditions

This isn't a complete list, and some of these are absolute reasons to avoid the medication while others simply require a more careful conversation. This is precisely the kind of thing a medical consultation exists to sort out — reviewing your history, your current medications, and your health goals to determine what's safe and appropriate for you.

Why the real answer comes from a consultation

An online article can tell you the general criteria. It can't tell you whether you qualify — because that depends on information only a clinical assessment can gather: your medical history, medications, other conditions, and goals.

A licensed healthcare provider will:

• Confirm your BMI and review any weight-related conditions

• Screen for the histories that would make semaglutide unsafe for you

• Discuss realistic expectations, including that the medication works best alongside sustainable lifestyle changes

• Determine the right starting dose and monitoring plan if treatment is appropriate

That last point matters: Health Canada authorized semaglutide as an adjunct to diet and physical activity — meaning it's designed to work with lifestyle change, not instead of it. A good provider frames it that way from the start.

The bottom line

If your BMI is 30 or higher, or 27 or higher with a weight-related health condition, you may be a candidate for GLP-1 weight management in Canada — but the only way to know for certain is a consultation with a licensed healthcare provider, who will look at your whole health picture rather than a single number.

At Kinro, that assessment is straightforward: a medical consultation reviews your eligibility, and if semaglutide is appropriate for you, your prescription and ongoing clinical support are coordinated through our own pharmacy.

Start your Consultation

This article is for general educational purposes and does not constitute medical advice, diagnosis, or treatment, and does not list every factor affecting eligibility. Semaglutide is a prescription medication authorized by Health Canada; it is not suitable for everyone, and eligibility is determined through a medical consultation with a licensed healthcare provider. Always consult your provider and review the product monograph before starting any treatment. Individual results vary.